The stock market seems to bounce back slightly following the biggest one-day drop ever recorded for the Dow and S&P 500. But markets remain volatile, causing many to speculate about what's behind the big ups and downs. Tom Essaye, founder and editor of The Seven's Report, says the fundamentals of the U.S. economy are strong and people shouldn't panic just yet.
The Falcon Heavy is finally scheduled to launch today. SpaceX will launch the rocket from Kennedy Space Center and attempt to land all three boosters. The rocket is carrying CEO Elon Musk's original Tesla Roadster. Musk says the rocket is the most powerful one in operation.
Lululemon's CEO is resigning. The company says Laurent Potdevin violated company's standards, though it was not immediately clear what standards he failed to comply with. Potdevin has been CEO since 2014. The company is now conducting a search for a new leader.
Plus, it's our weekly trading show, The Long and the Short. We discuss what to expect when Snap, Tesla, and Disney report quarterly earnings this week. And we also talk about whether the upcoming Valentine's Day holiday can help turn things around for 1-800-Flowers.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
